| Predicting PDZ domain–peptide interactions from primary sequences JR Chen, BH Chang, JE Allen, MA Stiffler, G MacBeath Nature biotechnology 26 (9), 1041-1045, 2008 | 173 | 2008 |
| Quantifying protein–protein interactions in high throughput using protein domain microarrays A Kaushansky, JE Allen, A Gordus, MA Stiffler, ES Karp, BH Chang, ... Nature protocols 5 (4), 773-790, 2010 | 85 | 2010 |
| A quantitative study of the recruitment potential of all intracellular tyrosine residues on EGFR, FGFR1 and IGF1R A Kaushansky, A Gordus, B Chang, J Rush, G MacBeath Molecular Biosystems 4 (6), 643-653, 2008 | 69 | 2008 |
| Linear combinations of docking affinities explain quantitative differences in RTK signaling A Gordus, JA Krall, EM Beyer, A Kaushansky, A Wolf‐Yadlin, M Sevecka, ... Molecular systems biology 5 (1), 235, 2009 | 67 | 2009 |
| A systematic family-wide investigation reveals that∼ 30% of mammalian PDZ domains engage in PDZ-PDZ interactions BH Chang, TS Gujral, ES Karp, R BuKhalid, VP Grantcharova, ... Chemistry & biology 18 (9), 1143-1152, 2011 | 62 | 2011 |
| Family-wide investigation of PDZ domain-mediated protein-protein interactions implicates β-catenin in maintaining the integrity of tight junctions TS Gujral, ES Karp, M Chan, BH Chang, G MacBeath Chemistry & biology 20 (6), 816-827, 2013 | 41 | 2013 |
| An N1–Hydrogen bonding model for flavin coenzyme F Guo, BH Chang, CJ Rizzo Bioorganic & medicinal chemistry letters 12 (2), 151-154, 2002 | 36 | 2002 |
| Guanidino compounds D Chu, RS Boyce, D Duhl, BH Chang US Patent 6,716,840, 2004 | 34 | 2004 |
| Corrigendum: Genome sequencing and analysis of the biomass-degrading fungus Trichoderma reesei (syn. Hypocrea jecorina) D Martinez, RM Berka, B Henrissat, M Saloheimo, M Arvas, SE Baker, ... Nature Biotechnology 26 (10), 2008 | 22 | 2008 |
| Guanidino compounds D Chu, R Boyce, D Duhl, B Chang US Patent 7,456,183, 2008 | 20 | 2008 |
| Substituted quinazolinone compounds RS Boyce, N Aurrecoechea, D Chu, A Smith, B Chang US Patent 7,034,033, 2006 | 20 | 2006 |
| Using CD69 PET imaging to monitor immunotherapy-induced immune activation KJ Edwards, B Chang, H Babazada, K Lohith, DH Park, MD Farwell, ... Cancer immunology research 10 (9), 1084-1094, 2022 | 15 | 2022 |
| Evaluation of the anti-PD-1 flare response in patients with advanced melanoma using FDG PET/CT imaging and hematologic biomarkers B Chang, A Huang, C Shang, K Palmer, E Schubert, W Xu, R Amaravadi, ... Journal of Nuclear Medicine 60 (supplement 1), 1270-1270, 2019 | 14 | 2019 |
| Development of a HER3 PET probe for breast cancer imaging E Wehrenberg-Klee, NS Turker, B Chang, P Heidari, U Mahmood Journal of Nuclear Medicine 55 (supplement 1), 550-550, 2014 | 10 | 2014 |
| Substituted dihydroisoquinolinone compounds RS Boyce, N Aurrecoechea, D Chu, A Smith, B Chang US Patent 7,858,641, 2010 | 6 | 2010 |
| FDG PET/CT Imaging 1 week after a single dose of pembrolizumab predicts treatment response in patients with advanced melanoma TM Anderson, BH Chang, AC Huang, X Xu, D Yoon, CG Shang, R Mick, ... Clinical Cancer Research 30 (9), 1758-1767, 2024 | 5 | 2024 |
| Substituted pyrido [2, 3-d] pyrimidinone compounds RS Boyce, N Aurrecoechea, D Chu, A Smith, B Chang US Patent 7,858,631, 2010 | 5 | 2010 |
| Compositions and Methods for Viral Inhibition ZJ Ni, B Chang, W Wang, A Weiner US Patent App. 10/576,045, 2007 | 3 | 2007 |
| Tracking Engineered T Cell Therapies with an RNA-based Reporter Gene B Chang, C Shang, K Lohith, M Farwell Journal of Nuclear Medicine 60 (supplement 1), 1605-1605, 2019 | 2 | 2019 |
| Lactam containing hcv inhibitors P Barsanti, N Brammier, B Chang, ZJ Ni, W Wang, A Weiner US Patent App. 11/917,299, 2009 | 1 | 2009 |
